BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2021 5:46:25 AM | Browse: 253 | Download: 706
Publication Name World Journal of Stem Cells
Manuscript ID 64069
Country China
Received
2021-02-08 08:08
Peer-Review Started
2021-02-08 08:11
To Make the First Decision
Return for Revision
2021-03-08 05:18
Revised
2021-03-10 03:30
Second Decision
2021-04-16 12:57
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-04-21 03:18
Articles in Press
2021-04-21 03:18
Publication Fee Transferred
Edit the Manuscript by Language Editor
2021-07-30 10:00
Typeset the Manuscript
2021-08-19 03:08
Publish the Manuscript Online
2021-08-20 05:46
ISSN 1948-0210 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cell Biology
Manuscript Type Minireviews
Article Title Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 infected pulmonary diseases: From bench to bedside
Manuscript Source Invited Manuscript
All Author List Lei-Sheng Zhang, Yi Yu, Hao Yu and Zhong-Chao Han
ORCID
Author(s) ORCID Number
Lei-Sheng Zhang http://orcid.org/0000-0001-6540-0943
Yi Yu http://orcid.org/0000-0002-1911-3692
Hao Yu http://orcid.org/0000-0002-8355-8741
Zhong-Chao Han http://orcid.org/0000-0002-1365-1844
Funding Agency and Grant Number
Funding Agency Grant Number
Shandong Provincial Natural Science Foundation ZR2020QC097
China Postdoctoral Science Foundation 2019M661033
Jiangxi key new product incubation program funded by Technical Innovation Guidance Program of Shangrao city 2020G002
Tianjin Science and Technology Project for Overseas Student JH-20180070802
Natural Science Foundation of Tianjin 19JCQNJC12500
Major Project of Fundamental Research Funds of the Central Public Welfare Scientific Research Institutes of the Chinese Academy of Medical Sciences 2018PT31048
Major Project of Fundamental Research Funds of the Central Public Welfare Scientific Research Institutes of the Chinese Academy of Medical Sciences 2019PT310013
National Science and Technology Major Projects of China for "Major New Drugs Innovation and Development" 2014ZX09508002-003
National Natural Science Foundation of China 81330015
Science and Technology Project of Tianjin 17ZXSCSY00030
Corresponding Author Hao Yu, PhD, Associate Professor, Postdoctoral Fellow, School of Medicine, Nankai University, No. 94 Weijin Road, Nankai District, Tianjin 300071, China. yuhao-wuhan@hotmail.com
Key Words Mesenchymal stem/stromal cells; COVID-19; Acute lung injury; Acute respiratory distress syndrome; Pulmonary fibrosis; Molecular mechanism
Core Tip Coronavirus disease 2019 (COVID-19) is a global pandemic and seriously threatens people’s lives. Due to the limitation of current traditional remedies as well as the rapid disease progression, inpatients with severe pulmonary manifestations and accompanied comorbidities are inclined to worse outcomes. Herein, we review the latest updates of the mesenchymal stem/stromal cells-based cytotherapy for COVID-19 management, together with discuss the principles and underlying molecular mechanisms as well, which will collectively benefit the novel comprehensive treatment for COVID-19 infected cases.
Publish Date 2021-08-20 05:46
Citation Zhang LS, Yu Y, Yu H, Han ZC. Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 infected pulmonary diseases: From bench to bedside. World J Stem Cells 2021; 13(8): 1058-1071
URL https://www.wjgnet.com/1948-0210/full/v13/i8/1058.htm
DOI https://dx.doi.org/10.4252/wjsc.v13.i8.1058
Full Article (PDF) WJSC-13-1058.pdf
Full Article (Word) WJSC-13-1058.docx
Manuscript File 64069_Auto_Edited_LM_LE.docx
Answering Reviewers 64069-Answering reviewers.pdf
Audio Core Tip 64069-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 64069-Conflict-of-interest statement.pdf
Copyright License Agreement 64069-Copyright license agreement.PDF
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 64069-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate 64069-Language certificate.pdf
Supplementary Material 64069-Supplementary material.pdf
Peer-review Report 64069-Peer-review(s).pdf
Scientific Misconduct Check 64069-Bing-Ma YJ-1.jpg
Scientific Misconduct Check 64069-Bing-Fan JR-2.png
Scientific Misconduct Check 64069-Scientific misconduct check.pdf
Scientific Editor Work List 64069-Scientific editor work list.pdf